Dr. Liu got his PhD at Peking University with the major of pathogenic organisms in 2019 and then did the postdoc at Princeton University from 2019 to 2024. In September 2024, Dr Liu joined Nanjing University and started his lab as a Principal investigator. Dr. Liu's research is focused on hepatitis viruses and liver cancer. Hepatitis B virus (HBV) is a major causative agent of chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC). HBV infection can be prevented with a prophylactic vaccine and antiviral therapy can suppress viremia but rarely leads to a cure and only decreases, but does not eliminate, the risk of further liver injury and HCC development. A major roadblock for developing more effective therapies and for gaining mechanistic insights into the pathogenesis of chronic hepatitis B is the scarcity of suitable animal models. Since Dr. Liu was a Ph.D. student, he have particular research interest on HBV and my research focus on the development of HCC, HBV virological characteristics, HBV animal model and its pathogenesis in the corresponding liver cancer. With specific training and expertise as a Ph.D. student and then postdoctoral researcher, Dr. Liu have a broad background in virology, cancer and animal model studies.
Dr. Liu got his PhD at Peking University with the major of pathogenic organisms in 2019 and then did the postdoc at Princeton University from 2019 to 2024. In September 2024, Dr Liu joined Nanjing University and started his lab as a Principal investigator. Dr. Liu's research is focused on hepatitis viruses and liver cancer. Hepatitis B virus (HBV) is a major causative agent of chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC). HBV infection can be prevented with a prophylactic vaccine and antiviral therapy can suppress viremia but rarely leads to a cure and only decreases, but does not eliminate, the risk of further liver injury and HCC development. A major roadblock for developing more effective therapies and for gaining mechanistic insights into the pathogenesis of chronic hepatitis B is the scarcity of suitable animal models. Since Dr. Liu was a Ph.D. student, he have particular research interest on HBV and my research focus on the development of HCC, HBV virological characteristics, HBV animal model and its pathogenesis in the corresponding liver cancer. With specific training and expertise as a Ph.D. student and then postdoctoral researcher, Dr. Liu have a broad background in virology, cancer and animal model studies.